Reversal of Multidrug Resistance of KBV200 Cells by Triterpenoids Isolated from Poria cocos

Abstract

Multidrug resistance (MDR) of tumor cells is one of the major problems encountered during cancer chemotherapy. In this paper, we isolated eight triterpenoids from Poria cocos and evaluated their effects on reversing MDR of KBV200 cells. Eight triterpenoids increase significantly vincristine-induced cytotoxicity in drug-resistant KBV200 cells at the concentrations of 12.5 µg/mL and 25 µg/mL. Dehydrotumulosic acid showed the best reversal effect: it increased KBV200 apoptosis induced by vincristine and inhibited P-gp function through enhancing the accumulation and retention of fluorescent P-gp substrate rhodamine 123 in KBV200 cells but had no effect on P-gp expression.

Key words

Poria cocos - Polyporaceae - triterpenoids - MDR - KBV200 cells - P-gp

References

• 1 Roninson I B, Abelson H T, Housman D E, Howell N, Varshavsky A. Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.  Nature. 1984;  309 626-628
• 2 Riordan J R, Deuchars K, Kartner N, Alon N, Trent J, Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.  Nature. 1985;  316 817-819
• 3 Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.  Cell. 1986;  47 371-380
• 4 Volm M. Multidrug resistance and its reversal.  Anticancer Res. 1998;  18 2905-2917
• 5 Limtrakul P, Siwanon S, Yodkeeree S, Duangrat C. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.  Phytomedicine. 2007;  14 381-389
• 6 Anuchapreeda S, Leechanachai P, Smith M M, Ambudkar S V, Limtrakul P N. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.  Biochem Pharmacol. 2002;  64 573-582
• 7 Ríos J L. Chemical constituents and pharmacological properties of Poria cocos.  Planta Med. 2011;  77 681-691
• 8 Qinglin Z, Jinghua Z, Jurong C, Jing S, Jianjin B, Xiaona W, Ping G, Zuze W. Screening of common traditional Chinese drugs for reversing multidrug resistance of KBV200 in vitro.  J Chin Pharm Sci. 2002;  11 64-67
• 9 Carmichael J, DeGraff W G, Gazdar A F, Minna J D, Mitchell J B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.  Cancer Res. 1987;  47 936-942
• 10 Tai T, Akahori A, Shingu T. Triterpenes of Poria cocos.  Phytochemistry. 1993;  32 1239-1244
• 11 Tai T, Akahori A, Shingu T. Triterpenes of Poria cocos.  Phytochemistry. 1991;  30 2796-2797
• 12 Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K. Isolation of inhibitor of TPA-induced mouse ear edema from hoelen, Poria cocos.  Chem Pharm Bull. 1996;  44 847-849
• 13 Cuélla M J, Giner R M, Recio M C, Just M J, Máñez S, Ríos J L. Two fungal lanostane derivatives as phospholipase A2 inhibitors.  J Nat Prod. 1996;  59 977-979
• 14 Zheng Y, Yang X W. Poriacosones A and B: two new lanostane triterpenoids from Poria cocos.  J Asian Nat Prod Res. 2008;  10 640-646
• 15 Keller A C, Maillard M P, Hostettmann K. Antimicrobial steroids from the fungus Fomitopsis pinicola.  Phytochemistry. 1996;  41 1041-1046
• 16 Tai T, Akahori A, Shingu T. Triterpenoid from Poria cocos.  Phytochemistry. 1992;  31 2548-2549
• 17 Ambudkar S V, Dey S, Hrycyna C A, Ramachandra M, Pastan I, Gottesman M M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter.  Annu Rev Pharmacol Toxicol. 1999;  39 361-398
• 18 Zhou L, Zhang Y, Gapter L A, Ling H, Agarwal R, Ng K Y. Cytotoxic and antioxidant activities of lanostane-type triterpenes isolated from Poria cocos.  Chem Pharm Bull (Tokyo). 2008;  56 1459-1462
• 19 Akihisa T, Uchiyama E, Kikuchi T, Tokuda H, Suzuki T, Kimura Y. Anti-tumor-promoting effects of 25-methoxyporicoic acid A and other triterpene acids from Poria cocos.  J Nat Prod. 2009;  72 1786-1792